DP

DP Aircraft I Limited

Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.

Overview

Corporate Details

ISIN(s):
GG00BBP6HP33
LEI:
213800IJ1Q9HI499AE41
Country:
Guernsey
Address:
EAST WING, GY1 3PP ST PETER PORT
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DP Aircraft I Limited is an investment holding company that specializes in the acquisition, leasing, and subsequent sale of aircraft. The company's investment objective is to generate income and capital returns for its shareholders. Its portfolio is focused on Boeing 787-8 aircraft, which it leases to commercial airlines. The company holds its aircraft assets through its subsidiaries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 17:22
Interim Report
Interim Report and Accounts
English 1.3 MB
2025-09-29 13:55
Interim Report
Interim Report and Accounts
English 646.7 KB
2025-03-27 16:51
Regulatory News Service
New Lease Agreements with LOT Polish Airlines
English 13.2 KB

Automate Your Workflow. Get a real-time feed of all DP Aircraft I Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DP Aircraft I Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.